PharmaTimesNews & Politicsnews

Sofinnova reports Myricx Bio to be acquired by Novartis

Monday, July 6, 2026John PinchingView original

Deal brings together Novartis oncology capabilities with Myricx Bio’s next‑gen ADC platform

Read the full article on the original site.